<DOC>
	<DOCNO>NCT00860119</DOCNO>
	<brief_summary>This study test assumption bioavailability alprazolam new sublingual formulation standard orally administer tablet .</brief_summary>
	<brief_title>Bioequivalence Alprazolam Sublingual v Oral Tablets</brief_title>
	<detailed_description />
	<mesh_term>Alprazolam</mesh_term>
	<criteria>Healthy male female subject BMI 17.5 30.5 Must provide inform consent Clinically significant disease Narrow angle glaucoma Positive drug screen</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Bioequivalence , Pharmacokinetics , Alprazolam , Sublingual</keyword>
</DOC>